FIG. 4.
Partial inhibition of LPS-induced CD26/DPPIV by anti-CD14 MAb. Confluent HGF (donor, NIK) were stimulated with E. coli LPS (10 μg/ml) for 6 days along with anti-CD14 MAb (MY4; 10 μg/ml) or isotype control mouse IgG2b (10 μg/ml), and then DPPIV assay was performed. The results are representative of two different experiments with two different donors (NIK and YS-G). Differences were significant at P < 0.05 (∗).